Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma × Immunotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 4 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Lung Neoplasms 2 Cholangiocarcinoma 2 Brain Neoplasms 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Locally Advanced Non-small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Deglutition Disorders 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Biliary Tract Neoplasms 1 Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 33 Vincristine 23 Etoposide 21 Cytarabine 19 Radiotherapy 17 Doxorubicin 17 Rituximab 16 Melphalan 16 Peripheral Blood Stem Cell Transplantation 14 Prednisolone 13 Filgrastim 13 Methotrexate 12 fludarabine phosphate 11 Prednisone 11 Dexamethasone 9 Carmustine 9 Bleomycin 9 Cyclosporine 8 Busulfan 8 Ifosfamide 7 Cisplatin 7 Vinblastine 6 Gemcitabine 6 Antilymphocyte Serum 6 sargramostim 5 pegylated granulocyte colony-stimulating factor 5 fludarabine 5 Mitoxantrone 5 Methylprednisolone 5 Chlorambucil 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06202885 2024-01-12

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Seoul St. Mary's Hospital

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡